RxSight (NASDAQ:RXST – Get Free Report) and Strategic Global Investments (OTCMKTS:STBV – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and earnings. Analyst Ratings This is a summary of current […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totalling 1,100,000 shares, a decrease of 16.7% from the November 30th total of 1,320,000 shares. Based on an average trading volume of 534,300 shares, the days-to-cover ratio is […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) insider Eric Weinberg sold 1,285 shares of RxSight stock in a transaction that occurred on Friday, December 22nd. The stock was sold at an average price of $40.00, for a total value of $51,400.00. Following the transaction, the insider now owns 339,978 shares of the company’s stock, valued […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) COO Ilya Goldshleger sold 5,000 shares of the business’s stock in a transaction on Friday, December 22nd. The shares were sold at an average price of $40.00, for a total transaction of $200,000.00. Following the sale, the chief operating officer now directly owns 26,475 shares in the company, […]
RxSight (NASDAQ:RXST – Get Free Report) and Strategic Global Investments (OTCMKTS:STBV – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends. Institutional & Insider Ownership 66.5% of RxSight shares […]